These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 1350264)

  • 1. Wiskott-Aldrich syndrome carrier detection with the hypervariable marker M27 beta.
    de Saint Basile G; Notarangelo LD; Bonaiti-Pellié C; Doussau M; Prolini O; Craig IW; Ugazio A; Griscelli C; Fischer A
    Hum Genet; 1992 May; 89(2):223-8. PubMed ID: 1350264
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier detection in Wiskott-Aldrich syndrome: combined use of M27 beta for X-inactivation studies and as a linked probe.
    Goodship J; Carter J; Espanol T; Boyd Y; Malcolm S; Levinsky RJ
    Blood; 1991 Jun; 77(12):2677-81. PubMed ID: 2043768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. X-chromosome inactivation in the Wiskott-Aldrich syndrome: a marker for detection of the carrier state and identification of cell lineages expressing the gene defect.
    Greer WL; Kwong PC; Peacocke M; Ip P; Rubin LA; Siminovitch KA
    Genomics; 1989 Jan; 4(1):60-7. PubMed ID: 2563352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Molecular genetic diagnosis of Wiskott-Aldrich syndrome].
    Orth U; Rosenkranz W; Schwinger E; Holzgreve W; Gal A
    Monatsschr Kinderheilkd; 1993 Sep; 141(9):728-31. PubMed ID: 8413349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of X-chromosome inactivation and presumptive expression of the Wiskott-Aldrich syndrome (WAS) gene in hematopoietic cell lineages of a thrombocytopenic carrier female of WAS.
    Notarangelo LD; Parolini O; Porta F; Locatelli F; Lanfranchi A; Marconi M; Nespoli L; Albertini A; Craig IW; Ugazio AG
    Hum Genet; 1991 Dec; 88(2):237-41. PubMed ID: 1684569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carrier detection in X-linked immunodeficiencies. II: An X inactivation assay based on differential methylation of a line-1 repeat at the DXS255 locus.
    Hinds H; Craig IW; Chen ZY; Kraakman ME; Schuurman RK; Hendriks RW
    Immunodeficiency; 1993; 4(1-4):213-5. PubMed ID: 8167703
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier detection in the Wiskott Aldrich syndrome.
    Fearon ER; Kohn DB; Winkelstein JA; Vogelstein B; Blaese RM
    Blood; 1988 Nov; 72(5):1735-9. PubMed ID: 3263154
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Localization of the gene for the Wiskott-Aldrich syndrome between two flanking markers, TIMP and DXS255, on Xp11.22-Xp11.3.
    Kwan SP; Lehner T; Hagemann T; Lu B; Blaese M; Ochs H; Wedgwood R; Ott J; Craig IW; Rosen FS
    Genomics; 1991 May; 10(1):29-33. PubMed ID: 1675197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis of Wiskott-Aldrich syndrome by analysis of the X chromosome inactivation patterns in maternal leucocyte populations using the hypervariable DXS255 locus.
    Hendriks RW; De Weers M; Mensink RG; Kraakman ME; Mollee-Versteegde IF; Veerman AJ; Sandkuyl LA; Schuurman RK
    Clin Exp Immunol; 1991 May; 84(2):219-22. PubMed ID: 1709069
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of molecular analysis to genetic counseling in the Wiskott-Aldrich syndrome (WAS).
    Notarangelo LD; Candotti F; Parolini O; Mantuano E; Giliani S; Lanfranchi A; Albertini A
    DNA Cell Biol; 1993 Sep; 12(7):645-9. PubMed ID: 8397823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ-line mosaicism simulates genetic heterogeneity in Wiskott-Aldrich syndrome.
    Arveiler B; de Saint-Basile G; Fischer A; Griscelli C; Mandel JL
    Am J Hum Genet; 1990 May; 46(5):906-11. PubMed ID: 1971143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Close linkage of hypervariable marker DXS255 to disease locus of Wiskott-Aldrich syndrome.
    de Saint Basile G; Arveiler B; Fraser NJ; Boyd Y; Graig IW; Griscelli G; Fischer A
    Lancet; 1989 Dec; 2(8675):1319-21. PubMed ID: 2574264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. X-linked thrombocytopenia and Wiskott-Aldrich syndrome: similar regional assignment but distinct X-inactivation pattern in carriers.
    De Saint-Basile G; Schlegel N; Caniglia M; Le Deist F; Kaplan C; Lecompte T; Piller F; Fischer A; Griscelli C
    Ann Hematol; 1991 Aug; 63(2):107-10. PubMed ID: 1912030
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Linkage studies of the Wiskott-Aldrich syndrome: polymorphisms at TIMP and the X chromosome centromere are informative markers for genetic prediction.
    Greer WL; Mahtani MM; Kwong PC; Rubin LA; Peacocke M; Willard HF; Siminovitch KA
    Hum Genet; 1989 Oct; 83(3):227-30. PubMed ID: 2571560
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Wiskott-Aldrich syndrome: refinement of the localization on Xp and identification of another closely linked marker locus, OATL1.
    Greer WL; Peacocke M; Siminovitch KA
    Hum Genet; 1992 Feb; 88(4):453-6. PubMed ID: 1346773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clonal analysis of human tumors with M27 beta, a highly informative polymorphic X chromosomal probe.
    Fey MF; Peter HJ; Hinds HL; Zimmermann A; Liechti-Gallati S; Gerber H; Studer H; Tobler A
    J Clin Invest; 1992 May; 89(5):1438-44. PubMed ID: 1349026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Variable X-chromosome DNA methylation patterns detected with probe M27 beta in a series of lymphoid and myeloid malignancies.
    Hodges E; Howell WM; Boyd Y; Smith JL
    Br J Haematol; 1991 Mar; 77(3):315-22. PubMed ID: 2012755
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic mapping of the Wiskott-Aldrich syndrome with two highly-linked polymorphic DNA markers.
    Kwan SP; Sandkuyl LA; Blaese M; Kunkel LM; Bruns G; Parmley R; Skarshaug S; Page DC; Ott J; Rosen FS
    Genomics; 1988 Jul; 3(1):39-43. PubMed ID: 2906042
    [TBL] [Abstract][Full Text] [Related]  

  • 19. X chromosome inactivation in fibroblasts of mentally retarded female carriers of the fragile site Xq27.3: application of the probe M27 beta to evaluate X inactivation status.
    Schmidt M; Du Sart D; Kalitsis P; Fraser N; Leversha M; Voullaire L; Foster D; Davies J; Hills L; Petrovic V
    Am J Med Genet; 1991; 38(2-3):411-5. PubMed ID: 1673316
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Wiskott-Aldrich syndrome in a female with skewed X-chromosome inactivation.
    Andreu N; Pujol-Moix N; Martinez-Lostao L; Oset M; Muñiz-Diaz E; Estivill X; Volpini V; Fillat C
    Blood Cells Mol Dis; 2003; 31(3):332-7. PubMed ID: 14636648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.